Natural Endo Tech (168330) has 3 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩3M ($2K) in reported transaction value. The earliest filing StockDrifts holds for Natural Endo Tech is dated 2023-02-27; the most recent is 2025-05-08. Across these filings the average return since disclosure is +2.18%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2025-05-08 | BUY | 장외매수 | 서흥 Seoheung | - | 1.0M | ₩1,960 | +51.0% | ₩2.0B ($1.4M) |
| 2025-05-08 | BUY | 장외매수 | 양주환 Joohwan Yang | Internal director | 700.0K | ₩1,960 | +51.0% | ₩1.4B ($953K) |
| 2025-03-17 | BUY | 장외매수 | 김희도 Kim Hee-do | CEO | 27.0K | ₩1,404 | +110.8% | ₩38M ($26K) |
| 2025-03-17 | BUY | 장외매수 | 서흥 Seoheung | - | 862.6K | ₩1,404 | +110.8% | ₩1.2B ($841K) |
| 2025-03-17 | BUY | 장외매수 | 박금덕 Park Geum-deok | Other non-executive directors | 150.0K | ₩1,404 | +110.8% | ₩211M ($146K) |
| 2023-04-27 | BUY | Market Buy | 김희도 Kim Hee-do | CEO | 300 | ₩2,905 | +1.9% | ₩872K ($605) |
| 2023-03-27 | BUY | Market Buy | 김희도 Kim Hee-do | CEO | 300 | ₩2,715 | +9.0% | ₩815K ($566) |
| 2023-02-27 | BUY | Market Buy | 김희도 Kim Hee-do | CEO | 328 | ₩3,095 | -4.4% | ₩1M ($705) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.